CRI and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family.
Discussion of the next wave of scientific advancements in immuno-oncology by panel of industry and academic leaders
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.
30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment
Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
We spoke with Rebecca A. Shatsky, M.D., about the current treatment landscape for patients with breast cancer, including immunotherapy and clinical trial options.
More than 200 patients, caregivers, and advocates attended an Immunotherapy Patient Summit in San Diego on Saturday, June 29, 2019.